# Invesco Health Care S&P US Select Sector UCITS ETF (XLVP) **Source:** https://fundology.uk/fund/xlvp · ISIN IE00B3WMTH43 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 30/09/2026, XLVP (Invesco Health Care S&P US Select Sector UCITS ETF, ISIN IE00B3WMTH43) closed at £639.35 on the London Stock Exchange. Its ongoing charge is 0.14% a year (about £14 on £10,000). Over the five years to 30/09/2026 its total return was +38.8%, or +8.5% after UK CPIH inflation. ## Summary Invesco Health Care S&P US Select Sector UCITS ETF is an exchange-traded fund (ETF) from Invesco, launched in 2009. It tracks the S&P Select Sector Capped 20% Health Care Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.14% a year — about £14 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£639.35** (30/09/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | XLVP | | ISIN | IE00B3WMTH43 | | Category | Healthcare | | Type | ETF | | Provider | Invesco | | Tracks | S&P Select Sector Capped 20% Health Care Index | | Income | Accumulating | | Ongoing charge | 0.14% a year (£14 per £10,000) | | Fund size | £309m | | Launched | 2009 | | Domicile | Ireland | ## Past returns (periods to 30/09/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +25.79% | +21.84% | income reinvested | | 3 years | +22.40% | +10.45% | income reinvested | | 5 years | +38.77% | +8.48% | income reinvested | Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund): 2022 +9.0%, 2023 −3.9%, 2024 +4.6%, 2025 +5.1%; 2026 to 30/09/2026 +13.2%. Returns of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: +29.3%; to 30/09/2025: −11.3%; to 30/09/2024: +9.8%; to 30/09/2023: −2.9%; to 30/09/2022: +16.2%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +9.0% | -0.2% | Price | | 2023 | -3.9% | -7.7% | Price | | 2024 | +4.6% | +1.1% | Price | | 2025 | +5.1% | +1.5% | Price | | 2026 to 30/09/2026 | +13.2% | +10.1% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 16.52% | -10.72% | | 3 years | 14.38% | -19.00% | | 5 years | 13.97% | -19.00% | ## Largest fall Volatility of Invesco Health Care S&P US Select Sector UCITS ETF in pounds, annualised from weekly returns to 30/09/2026: 16.5% over 1 year, 14.4% over 3 years, 14.0% over 5 years. Largest fall in the price of Invesco Health Care S&P US Select Sector UCITS ETF since October 2021, in pounds: −19.0% from 31/01/2025 to 23/05/2025. The lowest 12-month return of Invesco Health Care S&P US Select Sector UCITS ETF in pounds (price, with income reinvested in the fund) since January 2021 was −16.8% (12 months to 08/08/2025); the highest was +30.0% (12 months to 08/04/2022). On 30/09/2026 the price of Invesco Health Care S&P US Select Sector UCITS ETF was at its highest weekly close since October 2021, in pounds. ## Charges compared with similar funds Ongoing charge of Invesco Health Care S&P US Select Sector UCITS ETF 0.14% a year, as of 01/10/2026: 16 of the 17 other healthcare funds charge more, 0 the same and 1 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.14%** per year - ISA eligible: yes - SIPP eligible: yes ## Top holdings Largest positions (as of 17/08/2026): | Holding | Weight | |---|---| | Eli Lilly | 15.60% | | JOHNSON & JOHNSON | 10.50% | | AbbVie | 7.40% | | Unitedhealth Grp | 6.00% | | MERCK & | 5.60% | | Amgen | 3.80% | | Thermo Fisher Scientific | 3.60% | | Abbott Laboratories | 3.20% | | Gilead Sciences | 2.90% | | Pfizer | 2.50% | ## Where it invests Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed. ### By sector As published by Invesco, as of 17/08/2026. | Sector | Weight | |---|---| | Information Technology | 31.2% | | Consumer Discretionary | 23.4% | | Health Care | 21.3% | | Communication Services | 6.6% | | Financials | 5.9% | | Consumer Staples | 4.5% | | Materials | 3.0% | | Industrials | 2.5% | | Other sectors | 1.7% | ### By country As published by Invesco, as of 17/08/2026. | Country | Weight | |---|---| | United States | 83.0% | | United Kingdom | 5.4% | | South Korea | 4.6% | | Switzerland | 3.3% | | Finland | 2.1% | | China | 0.7% | | Netherlands | 0.4% | | Cayman Islands | 0.3% | | Other countries | 0.4% | All 59 holdings: https://fundology.uk/fund/xlvp/holdings --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.